{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Controversies in Hereditary Cancer Management *6158*
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Description
Cognate Code 6158Learning Objectives
After completing this continuing education activity you will be able to:
- Discuss the concept of "previvor"
- Identify patients at risk for hereditary cancer
- Demonstrate knowledge about screening and prevention, including timing of surveillance, preventive medication, and risk-reducing surgeries
- List limitations and comorbidities associated with these risk management strategies
- Provide long-term psychological support to those women predisposed to inherited cancers
Disclosures
Financial Disclosure: The authors did not report any potential conflicts of interest.
Price:
$25.00
Credits:
- ACOG 2.0 CME
The American College of Obstetricians and Gynecologists is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA PRA Category 1 Credit(s)
The American College of Obstetricians and Gynecologists designates this journal-based activity for a maximum of 2 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
College Cognate Credit(s)
The American College of Obstetricians and Gynecologists designates this journal-based activity for a maximum of 2 Category 1 College Cognate Credits. The College has a reciprocity agreement with the AMA that allows AMA PRA Category 1 Credits TM to be equivalent to College Cognate Credits.
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Professions:
Physician
Test Code: ONG0521
Published: April 8, 2021
Expires: 5/31/2024
Sources:
Obstetrics & Gynecology
Required Passing Score: 7/10 (70%)
Specialties:
OB/GYN
Topics:
Hereditary Cancer
,
Management